In ovarian cancer, intensity and locationof PPARγ immunostainingwere examined in 28 carcinoma cases along with 28 normal, benign or borderline cases.Twenty six of 28 carcinomas showed strongly positive PPARγ stainingcompared to 2 weak-staining cases in the control group. Here, PPARG is linked to ovarian cancer.